Get a first look at top-tier biomanufacturing projects! Registration is now open—connect directly with leading investors.
2026 (2nd) Yimao Bio-Manufacturing Industry Conference & Exhibition (Summer) will be held in Shanghai from 8 to 28.At the exhibition, we will invite2000+Attendee,100+Speaker,20+Premium exhibitors, featuring "Conference - Exhibition - Meeting - EventFour core modules focused on "fundamental research breakthroughs + cross-domain industrial implementation," providing comprehensive coverage.Medicine & Aesthetics, Bio-based Materials & Green Chemicals, Food & Agriculture, AI-Enabled SolutionsCore Focus: Deeply connecting top-tier research experts, industry leaders, innovative SMEs, investment firms, and upstream/downstream supply chains to create a benchmark event for the entire bio-manufacturing value chain.
First Look at the Initial Roadshow Projects! Roadshow project coverageMedicine & Aesthetics, Bio-based Materials & Green Chemicals, Food & Agriculture, AI-Enabled SolutionsCore Domain: Top-tier mentors and leading investment firms will gather on-site to build a professional platform for precise matching between high-quality projects and capital.
Preview Project Roadshows
Project Name
Multi-target Small Molecule Women's Health Product for Signal Pathways: Clears High-Risk HPV, Reverses Precancerous Lesions, Eliminates Uterine Fibroids, and Supports Menopause Management
Project Overview
In the field of women's health where effective drugs are scarce, we integrate traditional Chinese medicine wisdom with modern biotechnology to enhance bioavailability and clarify signaling pathways. Leveraging our multi-target advantage, we inhibit HPV E6/E7, activate p53, and modulate epigenetics, HIF-α, and TGF-β. This approach induces apoptosis in HPV-infected mucosal cells, achieves HPV clearance, reverses precancerous lesions, and inhibits uterine fibroid proliferation, fibrosis, and nodules. With compliant product sales and robust clinical data on safety and efficacy, this innovative drug offers a low-risk, high-reward transformation path. Backed by independent intellectual property rights and patents granted in China, the US, and Europe, our research has been published in the Journal of Medical Virology.
Roadshow Request
Seeking New-Co partnership for funding real-world data studies on innovative drugs, clinical trial approval acquisition, and commercialization.
Preview Project Roadshows
Project Name
AI-Personalized Multi-Target Peptide Tumor Vaccine Combined with Enhanced NK Cell Immunotherapy Program
Project Overview
Established four proprietary core technology platforms: AI-based neoantigen prediction, multi-target polypeptide synthesis, sustained-release polysaccharide adjuvants, and enhanced NK cell preparation. Holding multiple authorized invention patents, we have developed an original polypeptide vaccine combined with NK cell synergistic therapy. Focusing on high-value, broad-spectrum tumor targets WT1 and MUC1, we fill the domestic gap in localized pipelines for personalized WT1/MUC1 polypeptide vaccines combined with NK cell therapy. Compared to existing therapies such as PD-1 and CAR-T, our solution offers differentiated advantages including lower side effects, controllable costs, and scalable production. It covers multiple solid tumors, including lung cancer, breast cancer, colorectal cancer, and liver cancer, forming a complete chain solution that integrates with clinical radiotherapy/chemotherapy and includes efficacy monitoring. Current progress: 1, collaborating hospitals for breast cancer trials; 2, animal studies are ongoing.
Roadshow Requests
Clinical IIT Funding
ConferenceRoadshow SessionDoneOpen Call: A professional showcase for breakthrough, high-potential biomanufacturing innovation projects. Connecting founders, R&D leads, commercialization teams, investors, and pharmaceutical companies through offline matchmaking to enable technology deployment, pipeline collaboration, and end-to-end funding and scaling support.
If you focusMedicine & Aesthetics, Bio-based Materials & Green Chemicals, Food & Agriculture, AI-Enabled SolutionsIf you're looking to connect with industrial capital, collaborate with upstream and downstream biomanufacturing companies, and accelerate pilot-scale production and commercialization of your products, this is your stage.
Roadshow adopted10min pitch + 5min Q&AMode: Connect directly with top-tier venture capital firms and industry resources. Pitch slots are limited; the earlier you submit your materials, the sooner you gain access to industry resource matching opportunities.
